Özgür Tanrıverdi

37PUBLICATIONS
116CO-AUTHORS
AutoimmunityPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Aug 15, 2026
AA amyloidosis as a renal immune-related adverse event of immune checkpoint inhibitors: mechanisms, diagnosis, and management.

|Jul 07, 2026
Active Helicobacter pylori Infection and Survival Outcomes in De Novo Metastatic Colorectal Cancer: A Retrospective Cohort Study.

|Jun 12, 2026
Prognostic Role of Inflammatory Indices and Real-World Outcomes in HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine.

|May 27, 2026
Prognostic Value of the Prognostic Nutritional Index in Patients with Locally Advanced Bladder Cancer Receiving Perioperative Chemotherapy: A Multicenter Real-World Study.

|May 27, 2026
First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis.

|May 22, 2026
Impact of home-based port infusion versus hospital-based peripheral infusion on anxiety, quality of life, and emergency visits in gastrointestinal cancer: a prospective observational study by the Turkish Oncology Group (TOG).

Pageof 7

Frequent Collaborators

7 joint publications

Ali Alkan

2 joint publications

Kubra Canaslan

2 joint publications

Hüseyin Salih Semiz

2 joint publications

Öztürk Ateş